Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel

• Update on the SEAS Study
• Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
• /C O R R E C T I O N -- Prof Terje Pedersen,SEAS Study Principal Investigator& Head of Steering Committee/
• First Study in Real-Life Setting Confirms That Once-Monthly Mircera Keeps Haemoglobin Levels Within a Tight Range
• Sanofi Aventis : New Study Results Support the"Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
• Study Shows Machine Perfusion Significantly Improves Transplant Results
• Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
• Largest Study of its Kind Reveals Low Sexual Desire is Most Common Female Sexual Problem
• VELCADE(R) (bortezomib) Findings Reinforce Efficacy and Survival Across Multiple Patient Populations
• CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study

Seas - Österreich - E-Mail, Adresse, Telefonnummer und mehr! 123people.at

Release EMBARGO: 18.00/6pm BST, Monday 21 July 2008 Results from The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has investigated the effects of

Pressemitteilungen und Pressemeldungen vom 21.07.2008 | PresseEcho.de

of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study.21.07.2008 19:15 Uhr

Bankkaufmann - News

Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study.21.07.2008 The SEAS (Simvastatin andEzetimibe in Aortic Stenosis) study has

ots.at: das APA-OTS-Portal für multimediale Presseaussendungen

ots.at: das APA-OTS-Portal für multimediale Presse Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study = 21.07.2008 / 19:22

Presseportal: Prof Terje Pedersen, SEAS Study Principal Investigator ...

Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study PRNewswire) - The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has